SCHEDULE 13G/A: Balyasny Asset Management Discloses 9.99% Stake in Beyond Air, Inc.

Balyasny Asset Management and its affiliates have disclosed a beneficial ownership of 9.99% in Beyond Air, Inc.'s common stock, including shares issuable from warrants, as of March 31, 2025.

Summary

• Balyasny Asset Management L.P., along with its affiliates BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny (collectively, the "Reporting Persons"), have filed an Amendment No. 1 to Schedule 13G.
• The Reporting Persons collectively beneficially own 12,290,913 shares of Beyond Air, Inc. common stock.
• This ownership represents approximately 9.99% of Beyond Air, Inc.'s outstanding common stock.
• The total shares beneficially owned include 8,956,504 shares of common stock issuable upon the exercise of warrants.
• The percentage is calculated based on 88,278,647 shares outstanding as of February 10, 2025, as reported in Beyond Air's Quarterly Report on Form 10-Q.
• A 9.99% blocker provision in the warrants prevents the Reporting Persons from exercising warrants if it would result in beneficial ownership exceeding 9.99% of the outstanding common stock.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Beyond Air, Inc.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Schedule 13G is a factual disclosure, a significant stake by a reputable asset manager like Balyasny Asset Management can be interpreted as a positive signal of confidence in the issuer, Beyond Air, Inc. The explicit statement that the shares are held in the ordinary course of business and not for control purposes also reduces potential uncertainty.

Positives

• A significant institutional investor, Balyasny Asset Management, has disclosed a substantial stake (9.99%) in Beyond Air, Inc., which may signal confidence in the company's long-term prospects.
• The filing explicitly states that the shares were acquired and are held in the ordinary course of business, indicating a passive investment rather than an activist intent to influence control.

Negatives

• The 9.99% blocker provision on the warrants means that Balyasny Asset Management cannot increase its ownership beyond this threshold through warrant exercise, potentially limiting their ability to further capitalize on future stock appreciation from these specific instruments.

Risks

• The 9.99% Blocker provision limits the Reporting Persons' ability to fully exercise all their warrants if it would push their beneficial ownership above 9.99% of the outstanding common stock, which could impact their potential upside from these specific securities.

Future Outlook

The document does not provide forward-looking statements or guidance regarding Beyond Air, Inc.'s operational or financial performance. It solely pertains to the beneficial ownership stake of Balyasny Asset Management and its affiliates.

Industry Context

This filing indicates a significant investment by a prominent asset management firm in a company within the healthcare or biotechnology sector (implied by 'Beyond Air, Inc.' and its typical business areas). Such an investment can be viewed by the market as a vote of confidence, potentially influencing investor sentiment within the industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor like Balyasny Asset Management may instill confidence and potentially attract other investors, positively impacting share price.
• Company Management: Awareness of a large institutional holder may influence strategic decisions, though the filing states the investment is passive and not for control.

Key Dates

Keywords

Beyond Air Inc, Balyasny Asset Management, Schedule 13G, Beneficial Ownership, Common Stock, Warrants, Institutional Investor, SEC Filing, Equity Stake, Investment Management